Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirogabalin for paclitaxel-induced peripheral neuropathy in primary breast cancer
jRCTs031220001Completed
- Sponsor
- University of Tsukuba Hospital
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of mirogabalin in peripheral neuropathy, sponsored by University of Tsukuba Hospital. Primary endpoint: Change in peripheral neuropathy intensity (VAS). Started Apr 2022; status: completed.
02
Drugs
mirogabalin
03
Conditions
peripheral neuropathy
Beyond the preview
Go deeper on jRCTs031220001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031220001.